These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23945031)

  • 1. The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate.
    Ibrahim S; Jespersen J; Poller L;
    J Thromb Haemost; 2013 Aug; 11(8):1540-6. PubMed ID: 23945031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
    Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W
    Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.
    Kovacs MJ; Rodger M; Anderson DR; Morrow B; Kells G; Kovacs J; Boyle E; Wells PS
    Ann Intern Med; 2003 May; 138(9):714-9. PubMed ID: 12729425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.
    Kearon C; Ginsberg JS; Kovacs MJ; Anderson DR; Wells P; Julian JA; MacKinnon B; Weitz JI; Crowther MA; Dolan S; Turpie AG; Geerts W; Solymoss S; van Nguyen P; Demers C; Kahn SR; Kassis J; Rodger M; Hambleton J; Gent M;
    N Engl J Med; 2003 Aug; 349(7):631-9. PubMed ID: 12917299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
    Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR.
    Janes S; Challis R; Fisher F
    Clin Lab Haematol; 2004 Feb; 26(1):43-7. PubMed ID: 14738437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    Int J Clin Pharm; 2015 Feb; 37(1):53-9. PubMed ID: 25428444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
    Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
    Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].
    Bauersachs RM
    Internist (Berl); 2003 Dec; 44(12):1491-9. PubMed ID: 14689191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
    Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
    Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
    Hylek EM; Skates SJ; Sheehan MA; Singer DE
    N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
    Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.